Deal Diary

Welcome to Acquisition International’s Deal Diary, the place where we showcase exciting deals from across the globe. With each diary entry, we’ll be taking a comprehensive look at the inner workings of the deal in question and will be venturing behind the scenes to take a look at the dedicated professionals involved in ensuring its success.

Here you will discover the most active deal makers and a comprehensive catalogue of the transactions they have been involved with.

Tier 1: The Website - Go live worldwide within 24 hours!

Within 24 hours of booking, we'll upload your deal and company profile - including contact details and links to your homepage - right here on our site, putting you and your firm in front of
40,000 visitors every month!

You will, of course, get a full company bio, including your contact details and fully clickable links direct to your website, and to make sure the people who matter will be able to find every deal you and your firm have been involved in at the click of a button, all of the deals posted on the Deal Diary site are incredibly easy to search by firm name, individual name, sector or region. We even have an automatically updated deal leaderboard (right). 

Tier 2: The Newsletter - Direct to 108,000 subscribers!

Your involvement in the deal will be featured on our weekly Deal Round-Up newsletter,  published via email every Thursday to a global audience of  108,000. Your deal write-up will also include hyperlinked images and logos, taking readers straight to your homepage. That’s a potential 108,000 clicks every month!

Tier 3: The Publication - Sent to 108,000 people in 170 countries!

The deal and your involvement will appear in the Deal Diary section of our monthly magazine, distributed to 108,000 people in 170 countries around the world. This is where you can tell us all about the deal and how you made it happen, providing the perfect opportunity to shout about your firm’s experience, expertise and the great work you’ve been doing.

GO

Antal Acquires Smart Moves
May 27, 2015
APS Foods Acquisition of Wight Salads
May 27, 2015
Morgan Tucker Acquisition of BES Consulting Engineers
May 27, 2015
Wirtualna Polska Holding IPO
May 27, 2015
Access Technology's Acquisition of Changeworknow
May 21, 2015
Drillisch's Acquisition of Phone House Germany
May 21, 2015
XPO Logistics to Acquire Bridge Terminal Transport
May 21, 2015
Kodiak's Acquisition of Zarsky Lumber
May 21, 2015
Merkle's Acquisition of Periscopix
May 21, 2015
Apax's Acquisition of Quality Distribution
May 21, 2015
Biocon to go Ahead with Syngene IPO, Listing Likely in July
May 19, 2015
Gleiss Lutz Advises Yemeksepeti-Anteilseigner During Delivery Hero Acquisition
May 19, 2015

Biocon to go Ahead with Syngene IPO, Listing Likely in July

View Biography
Amarchand & Mangaldas

Biopharmaceuticals major Biocon on Tuesday said that the unlocking of the value from its contract research subsidiary Syngene would help the company fund its research and development programmes.

Syngene has already filed the draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (SEBI), seeking approval for an initial public offering (IPO). The company is estimated to be raising around Rs 600 crore through this public issue.

"We are unlocking value from Syngene to fund our R&D programmes, which include a rich pipeline of biosimilars and novel biologics. This fund infusion will help accelerate these programmes which are at various stages of development currently," said Kiran Mazumdar-Shaw, chairperson and managing director, Biocon.

This is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene. Biocon along with its subsidiary Biocon Research Limited (BRL), currently holds an 84.5 per cent equity stake in Syngene. The company is offering to sell up to 22 million equity shares of face value of Rs 10 each, through Syngene's IPO.

The offer includes a reservation of two million equity shares for Biocon's public equity shareholders, being individuals and Hindu Undivided Families (HUFs). The offer would constitute 11 per cent of the post offer paid-up equity share capital of the company.

Established in 1993, Syngene offers a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies. The company's service offerings also support the development of biosimilar and generic molecules.

During the nine months period-ended December 31, 2014, Syngene serviced 195 clients, ranging from multinational corporations to start-ups, including seven of the top 10 global pharmaceutical companies by sales for 2014.

Syngene had reported revenues of Rs 707.7 crore for the previous financial year-ended March 31, 2014 and Rs 617.5 crore for the nine months period ended December 31, 2014. Earlier this month, the company appointed Peter Bains as its Chief Executive Officer. Bains has been a part of Syngene since January 2010 as a director and has more than two decades of experience in the pharmaceutical space.

"Syngene has a proven track record of providing quality NME discovery, development and manufacturing services. It has long-standing partnerships with three of the world's leading global healthcare organisations, including Bristol-Myers Squibb Co. and has attracted equity participation from India Value Fund recently, which is reflective of the scale, the value and the quality of the differentiated business model of Syngene," added Mazumdar-Shaw.

Gleiss Lutz Advises Apax Partners During Acquisition of Azelis
May 19, 2015
Browne Jacobson advises LDC on £25m Aspin Group investment
May 14, 2015
RINA Services Acquires QIC Inc. to Expand Oil and Gas Services
May 14, 2015
Antin Infrastructure to Buy BP’s stake in Central Area Transmission System
May 14, 2015
Blablacar Acquisition of Carpooling.com
May 14, 2015
Charterhouse's Acquisition of Stake in Comexposium
May 14, 2015
Well Acquires Care4U Pharmacy
May 14, 2015
Finasta Banking Business is Planned to be Integrated With Šiaulių bankas
May 14, 2015
MORE...
Share this page:
Copyright Acquisition Intl. 2016